Note 10 - Equity (Tables)

3 Months Ended

Mar. 31, 2023

Stockholders' Equity Note [Abstract]

Summary of Stock-Based Award Activity

The following table summarizes the stock-based award activity under the Plan for the three months ended March 31, 2023 and 2022.

	Restricted Stock Awards			Weighted-Average Grant Date Fair Value Per Restricted Stock Award
Outstanding as of December 31, 2022		159,439		$	2.24
Vested		(59,607	)		2.25
Forfeitures		(6,695	)		2.95
Outstanding as of March 31, 2023		93,137		$	2.23

	Restricted Stock Awards			Weighted-Average Grant Date Fair Value Per Restricted Stock Award
Outstanding as of December 31, 2021		237,621		$	1.26
Vested		(172,580	)		0.75
Outstanding as of March 31, 2022		65,041		$	0.51

Of the restricted shares that vested during the three months ended March 31, 2023, 4,126 shares were surrendered by certain employees to satisfy their tax obligations.

Summary of Option Awards

In connection with the completion of the Initial Mergers, the Company assumed option awards previously issued to directors and officers of MedAmerica. Details of these options for the three months ended March 31, 2023 and 2022 are presented in the tables below:

	Number of Shares Underlying Options		Weighted Average Exercise Price Per Share		Weighted Average Fair Value at Grant Date		Weighted Average Remaining Contractual Life		Intrinsic Value
Balance at December 31, 2022		10,000	$	6.00	$	—		0.45	$	—
Options granted		—		—		—		—		—
Options exercised		—		—		—		—		—
Options expired		—		—		—		—		—
Balance at March 31, 2023		10,000	$	6.00	$	—		0.20	$	—

	Number of Shares Underlying Options		Weighted Average Exercise Price Per Share		Weighted Average Fair Value at Grant Date		Weighted Average Remaining Contractual Life		Intrinsic Value
Balance at December 31, 2021		70,000	$	7.71	$	—		0.76	$	—
Options granted		—		—		—		—		—
Options exercised		—		—		—		—		—
Options expired		—		—		—		—		—
Balance at March 31, 2022		70,000	$	7.71	$	—		0.51	$	—